en
Scientific article
Open access
English

CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort

Published inActa neuropathologica, vol. 140, no. 3, p. 405-407
Publication date2020-09
First online date2020-06-08
Keywords
  • Cohort Studies
  • Cyclin-Dependent Kinase Inhibitor p16 / deficiency
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Ependymoma / diagnosis
  • Ependymoma / drug therapy
  • Ependymoma / metabolism
  • Ependymoma / pathology
  • Humans
  • Prognosis
  • Supratentorial Neoplasms / metabolism
  • Supratentorial Neoplasms / pathology
  • Transcription Factor RelA / metabolism
Citation (ISO format)
JÜNGER, Stephanie T et al. <i>CDKN2A</i> deletion in supratentorial ependymoma with <i>RELA</i> alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort. In: Acta neuropathologica, 2020, vol. 140, n° 3, p. 405–407. doi: 10.1007/s00401-020-02169-z
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0001-6322
83views
27downloads

Technical informations

Creation10/15/2021 10:46:00 AM
First validation10/15/2021 10:46:00 AM
Update time03/16/2023 2:08:25 AM
Status update03/16/2023 2:08:23 AM
Last indexation05/06/2024 8:40:19 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack